home / stock / ovid / ovid news

OVID News and Press, Ovid Therapeutics Inc. From 03/28/19

Stock Information
Company Name: Ovid Therapeutics Inc.
Stock Symbol: OVID
Market: NASDAQ
Website: ovidrx.com
Menu
OVID OVID Quote OVID Short OVID News OVID Articles OVID Message Board
Get OVID Alerts

News, Short Squeeze, Breakout and More Instantly...
OVID - Ovid Therapeutics Announces Senior Management Changes to Align Expertise with Advancing Clinical Stage Pipeline

NEW YORK, March 28, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today announced changes to its senior management team to focus the company&#...
OVID - Ovid Therapeutics reports Q4 results

Ovid Therapeutics (NASDAQ: OVID ): Q4 GAAP EPS of -$0.52. More news on: Ovid Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

OVID - Ovid Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today reported financial results for the fourth quarter and full year ended ...

OVID - Ovid Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11

NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that Jeremy Levin, DPhil, MB BChir, Chairman and Chief E...
OVID - Midday movers and shakers

Gainers:  Kandi Technologies Group (NASDAQ: KNDI ) +47% . LeMaitre Vascular (NASDAQ: LMAT ) +28% . AzurRx BioPharma (NASDAQ: AZRX ) +29% . Blink Charging (NASDAQ: BLNK ) +21% . Carrols Restaurant Group (NASDAQ: TAST ) +17% . OneSpan (NASDAQ: OSPN ) +17% . Garmin (NASDAQ: GRMN ) ...

OVID - Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock

NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced the pricing of underwritten public offerings of (i) 12,50...

OVID - Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock

NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it intends to offer and sell shares of its common stock a...
OVID - Ovid Therapeutics (OVID) Presents At Baird's Global Healthcare Conference - Slideshow

The following slide deck was published by Ovid Therapeutics Inc. in conjunction with this Read more ...

OVID - Dr. Yaron Werber, Chief Business and Financial Officer, to Return to Wall Street

Dr. Werber will join Cowen and Company as Managing Director and Senior Biotechnology Analyst effective September 24, 2018 Ovid has initiated a search to select a new CFO NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company comm...

OVID - Ovid Therapeutics to Present at Two Investor Healthcare Conferences in September 2018

NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that the company will present at two upcoming investor conferen...
Previous 10 Next 10